Can You Trust Your Semen Analysis Results?

Introduction

Semen analysis is a cornerstone test for evaluating male fertility, providing key parameters such as sperm count, motility (movement), and morphology (shape). Traditionally, these parameters are measured manuallyby trained laboratory technicians using microscopes and counting chambers. In recent decades, computer-assisted semen analysis (CASA) systems have emerged as an automated alternative, using cameras and software to analyze sperm samples. This article offers an unbiased, evidence-based review of manual versus CASA-based semen analysis – highlighting popular systems. We will compare their performance, the need (or not) for human intervention, regulatory approvals (including FDA-approved devices in the United States), and discuss why a properly performed manual semen analysis is often more costly and sometimes preferred for clinical diagnosis and treatment. The goal is a clear factual comparison accessible to both patients and healthcare professionals.

Manual Semen Analysis: The Traditional Approach

Manual semen analysis is conducted by skilled laboratory personnel (often andrologists or embryologists) following standardized protocols, such as those outlined in the World Health Organization (WHO) Laboratory Manual. Key steps in a comprehensive manual analysis include: measuring semen volume, assessing viscosity and pH, determining sperm concentration (count) with a counting chamber (hemocytometer or Makler chamber), evaluating motility by observing sperm movement under a microscope, and examining morphology by staining sperm on slides and classifying their shape against strict criteria. Additional assessments like sperm viability (vital staining), presence of white blood cells or clumping (agglutination), and specialized tests (DNA fragmentation, etc.) may also be performed.

Performing a manual analysis “correctly” is labor-intensive and requires expertise. Technicians must meticulously mix the sample (sperm cells can settle or cluster), load it properly into chambers, and count or classify hundreds of cells across multiple fields of view to get reliable averages. The WHO guidelines demand rigorous training and quality control to minimize variability[1][2]. Even so, manual microscopy is inherently subjective – different technicians might produce slightly different results, especially for subtle assessments like what constitutes a “normal” morphology. In fact, variability in manual results between laboratories is a well-documented challenge, often due to inconsistent adherence to standard methods[3].

Advantages of manual analysis: A well-trained human observer can account for context and subtle details in ways machines struggle to. For example, an expert can recognize when debris or cells clumped together are falsely appearing as a single sperm, and exclude those artifacts. They can adjust focus or lighting to better visualize structures, use judgement on “borderline” forms, and note relevant observations like the presence of infection or sperm agglutination. The human eye and brain can integrate many visual cues – an experienced embryologist “understands the context” and knows when results look aberrant and require double-checking[4][5]. Especially for sperm morphology, manual assessment by an expert under high magnification (often with strict Kruger criteria and special staining) is considered the gold standard in clinical practice[6]. Fine details such as tiny head vacuoles, subtle acrosome defects, bent necks, or borderline abnormalities can be appreciated by a skilled person, whereas current automated systems either don’t stain the sperm or lack the resolution to reliably distinguish these features[6]. In summary, manual analysis allows flexibility and clinical insight – the technician can tailor the approach to the sample (using different microscope objectives or stains if needed) and provide qualitative comments (e.g. “many round cells suggestive of infection” or “sperm agglutination observed”) that an automated printout might not[7].

Drawbacks of manual analysis: The flip side of human involvement is subjectivity and variability. Counting moving sperm by eye is prone to human error; one person’s estimate of “50% motile” could be ten percentage points off from another’s if not carefully standardized. Fatigue or inexperience can lead to inconsistent results. Manual morphology assessment is notoriously variable – what one lab calls 4% “normal forms” another might call 6% on the same sample, due to differences in technique or strictness. Indeed, a systematic review found that among semen parameters, morphology results showed the greatest discrepancies between different evaluators because of heterogeneity in sperm shapes and subjective interpretation[8][9]. Manual analysis also takes more time. A thorough semen exam (including morphology) can easily take 45 minutes to an hour of a technician’s time, especially if hundreds of cells must be examined. This labor requirement is a major reason a comprehensive manual semen analysis – when done to high standards – often costs more than automated or rapid tests. You’re essentially paying for the expert’s time and meticulous attention to detail. In clinical practice, some high-volume labs shortcut the process (for example, doing only 100 sperm for morphology or skipping certain observations) to save time, but that can reduce accuracy. A truly careful manual analysis is a resource-intensive service.

Finally, manual methods have limits in precision. Humans can’t easily track the exact speed or trajectory of a sperm cell with the naked eye – they categorize motility qualitatively (e.g. rapid progressive, slow, non-progressive, immotile) rather than measuring exact velocities. And while an experienced technician strives to be consistent, day-to-day and person-to-person variation is inevitable. These limitations were part of the motivation for developing automated CASA systems to bring more objectivity and consistency to semen analysis[10][11].

Computer-Assisted Semen Analysis (CASA): Automation in Andrology

Computer-Assisted Semen Analysis (CASA) refers to a category of automated systems that use digital imaging and software algorithms to analyze semen samples. First introduced in the 1980s, CASA systems were designed to reduce operator subjectivity and improve standardization[12]. A typical CASA setup includes a microscope equipped with a special digital video camera and a computer. The software captures live or recorded video frames of sperm moving in the sample and automatically calculates parameters like sperm concentration, motion characteristics, and sometimes morphology, by identifying sperm in the images. Essentially, CASA “sees” sperm as pixels on a screen and tracks their movement frame-to-frame, measuring velocities and motion patterns that a human observer could only roughly estimate[11][13].

How CASA works (image analysis): For motility and count, the software usually analyzes several microscopic fields, detecting sperm heads in each frame. By linking the positions of each sperm across many video frames, it calculates trajectories and speeds. This yields detailed metrics such as average path velocity, straight-line velocity, linearity of motion, etc., in addition to the basic percentage of motile sperm (and the subset that are progressively motile). For concentration, CASA can count the sperm heads in the fields (similar to manual counting, but done via image recognition). Many CASA systems require the sample to be loaded into a disposable chamber with fixed depth, ensuring a known volume for accurate concentration calculations. For morphology, CASA systems (if equipped for it) typically capture high-resolution still images of stained sperm and perform morphometric analysis – measuring head size, ovalness, acrosome size, tail length, etc., and classifying sperm as normal or abnormal based on programmed criteria.

Over the years, CASA technology has improved significantly. Early generations of CASA in the 1990s were notorious for lacking precision, often missing sperm that overlapped or misidentifying debris as sperm[14]. In fact, a 1998 ESHRE (European Society of Human Reproduction and Embryology) consensus warned that results from then-current CASA systems should be “taken with caution” due to such errors[14]. Since then, software and hardware advances – better image resolution, improved focus systems, and refined algorithms – have enhanced CASA accuracy[15]. Modern CASA software can apply filters to ignore particles that don’t match sperm size/shape, and can distinguish (to some extent) a sperm head that is moving under its own power versus one drifting passively. Nonetheless, CASA still has limitations, especially when confronted with unusual samples (e.g. very high debris, clumped sperm, very low counts). We will delve into these issues in the comparison section.

It’s important to note that “CASA” is somewhat broad – it encompasses any computer-aided sperm analysis. There are two main technological approaches in today’s market:

• Video image analysis CASA: These are systems that literally analyze microscope video images of sperm. Examples include Microptic’s SCA (described below) and earlier systems like Hamilton Thorne’s IVOS/CEROS. They output detailed kinematic data and often provide actual images or videos of the sperm tracks. Most CASA research publications refer to this type.
• Electro-optical signal analysis: This is a different automated method used by devices like the SQA series (Sperm Quality Analyzers) from Medical Electronic Systems. Instead of analyzing a camera image of sperm swimming, the SQA devices pass the sample through an optical chamber and detect changes in light transmission as sperm cells move. These changes are converted into electrical signals, and proprietary algorithms interpret them to estimate concentration, motile fraction, etc.[16]. Essentially, it’s analogous to a particle counter or spectrophotometer approach. SQA systems also use spectrophotometry to measure concentration (light absorbance proportional to sperm count)[17][18]. Because of this unique design, SQA analyzers can churn out results extremely quickly (on the order of 1–2 minutes per sample) and with a high degree of repeatability for the parameters they measure. However, early models did not provide visual feedback or detailed morphology, which led to some criticism that you were trusting a “black box” measurement. Newer SQA models have added imaging capabilities to capture and display sperm images for verification (more on that shortly).

Popular CASA Systems on the Market: Let’s highlight a few well-known CASA solutions, , and note their features and status:

• Microptic Sperm Class Analyzer (SCA): The SCA is a modular CASA software platform developed by Microptic (Spain), often distributed by Hamilton Thorne in the US[19][20]. It’s an image analysis system following WHO criteria, capable of measuring motility, concentration, morphology, vitality, DNA fragmentation, and other parameters by adding appropriate modules[21][22]. A typical SCA setup involves a high-quality phase-contrast microscope with a digital camera, a computer running the SCA software, and optionally a motorized stage and auto-focus. The SCA can be used for humans and even adapted for veterinary or research use across species[23]. One reason it’s popular is flexibility: labs can start with just the motility/count module and later add morphology or DNA fragmentation modules as needed. The system captures video of sperm for motility and images of stained smears for morphology, then analyzes them automatically. However, Microptic’s standard SCA system is not fully hands-off – a lab technician typically needs to prepare the sample (dilute if necessary), load it into a chamber, place it on the microscope, and either manually focus/choose fields or use an automated stage if available. In practice, many labs using SCA will still have a technician oversee the analysis (to ensure correct focus and that the software isn’t counting debris, etc.) and then review the results. Microptic has recently introduced SCA SCOPE, an all-in-one hardware+software device aimed at full automation[24]. The SCA SCOPE contains an integrated microscope, motorized stage (that can examine up to 4 slides in one run), auto-focus optics, and the SCA software – packaged as a single instrument. It automatically selects microscope objectives, adjusts illumination, and even performs internal quality checks without user input[25][26]. In essence, SCA SCOPE is designed so that a non-expert can load the semen sample slides and press “start,” and the machine handles everything: focusing, capturing images, analyzing, and reporting. Human intervention is not required during analysis, according to the manufacturer, and it can finish a full panel (motility, count, morphology, etc.) in under 4 minutes[27][28]. This makes it one of the first completely automated CASA devices. However, at present the SCA SCOPE is labeled for research use in the US – it is not FDA approved for clinical diagnostics in the United States[29] (it does carry CE marking for use in Europe). U.S. labs using Microptic SCA generally use it as an adjunct or under their own validation rather than as an FDA-cleared IVD device.
• Medical Electronic Systems SQA-Vision (and SQA series): The SQA line of analyzers represents the alternative approach (electro-optical analysis). SQA-Vision is a laboratory semen analyzer that has been widely adopted in clinics, including many IVF centers and even the U.S. military labs[17][30]. Importantly, it is FDA-cleared in the U.S. as an automated semen analysis device[17]. The technology behind SQA-Vision involves measuring light signals disrupted by sperm movement, combined with spectrophotometric reading for concentration[31]. In practical terms, to run a sample, a technician loads a measured volume of semen into a disposable capillary or cartridge and inserts it into the machine[32][33]. The analysis (count and motility) completes in about 75 seconds[33]. SQA-Vision reports parameters like sperm concentration, percent motile, percent progressively motile, and even an index of normal morphology (sometimes called “Morphology Index” or percent “normal forms”) along with derived metrics like total motile count[16]. Because it doesn’t rely on a microscope image for basic parameters, it can be very fast and consistent. However, earlier SQA models (e.g., SQA-II, SQA-III, SQA-V Gold) had the drawback that users could not actually see the sperm – they had to trust the internal readings for morphology or motility. To address this, the SQA-Vision model and the latest SQA-iO incorporate a digital interface called SQA-V™ (or SQA-VU) that lets users view sperm images and even capture video frames for review[34]. Essentially, SQA-Vision can function in two modes: a fully automated “quick test”mode for rapid objective results, and a “visual confirm” mode where you can use it like a digital microscope to examine sperm morphology, vitality, etc. In fact, the manufacturer specifies that certain advanced analyses like detailed morphology, vitality staining, and DNA fragmentation are “semi-automated” – meaning the device can assist but a human may need to do preparation or confirmation[35][36]. For example, the SQA-Vision can automatically compute a percentage of morphologically normal sperm, but if a clinic needs a full differential morphology (categorizing specific defects) or verification, a technician might review saved images or perform a manual stained slide exam. The SQA-Vision is marketed as a high-throughput solution (running many samples per day with minimal hands-on time) and emphasizes standardization – it comes pre-calibrated to correlate with WHO 5th edition manual counts[37] and is used in proficiency testing programs with good results[38]. Its results have been compared against manual methods and other CASA in studies, generally showing close agreement (discussed later)[39]. SQA-Vision and its successor models (like the newer SQA-iO, which is a more compact, networked version) are among the few fully automated semen analyzers with FDA approval for clinical use in the U.S.[40]. This makes them attractive to labs that want automation but also need regulatory compliance.
• Hamilton Thorne CASA Systems: Hamilton Thorne is a long-standing company in reproductive tech. They produced some of the early CASA image-analysis systems such as IVOS and CEROS. These systems (first developed in the 1980s and improved through the early 2000s) are microscope-and-camera based CASA similar to Microptic’s concept. For instance, the Hamilton Thorne CEROS system was used in research and some clinics; one study noted it was an older (circa 2003) CASA model that nonetheless performed well in comparisons[41]. In recent years, Hamilton Thorne began collaborating with Microptic – they distribute the SCA software and the newer SCA SCOPE device. The Hamilton Thorne branding of SCA SCOPE highlights it as “the first totally automated device” for semen analysis[42]. However, like the Microptic parent product, it is for research use only in the USAcurrently[29]. Hamilton Thorne’s CASA systems have been widely used in animal breeding and research as well as human clinics around the world, but it’s worth noting that those systems (IVOS, CEROS) were generally not FDA-cleared either; labs using them would validate them internally. So in terms of regulatory status, Hamilton Thorne systems in human clinical labs would be considered laboratory-developed tests unless paired with an FDA-cleared algorithm.
• Other Notable Systems: There are other CASA solutions, though less common. For example, MedeaLab CASA (Germany) or AndroVision by Minitube (for veterinary/human use) are available for specialized applications. Additionally, the concept of CASA has extended to consumer devices – notably the YO Home Sperm Test. The YO test is essentially a mini-CASA for home use: it uses a smartphone camera with a small optical attachment to analyze a semen sample’s motile sperm concentration (MSC). Interestingly, the YO device is FDA-cleared for over-the-counter sale and uses image analysis (video of sperm on the phone) to report whether motile sperm count is above or below a threshold[43][44]. It’s not a full semen analysis, but it shows how CASA technology can be scaled down. (Of course, YO is intended as a screening tool and not a replacement for lab analysis[45][46].)

For this discussion, we will focus on the mainstream clinical systems (Microptic SCA, SQA-Vision, etc.) and how they compare with manual analysis in practice.

Performance Comparison: CASA vs. Manual Analysis

How do automated CASA results stack up against the traditional manual semen analysis? Numerous studies and reviews have addressed this question, and overall, the consensus is that CASA can produce comparable results for many parameters, but with some important caveats. Here we break down the comparison by parameter and consider the pros and cons, guided by evidence:

1. Sperm Concentration (Count): For sperm count (concentration of sperm per milliliter), CASA and manual hemocytometer counts are generally in strong agreement. A systematic review of 14 studies found a high correlation between manual and CASA-based sperm concentration measurements[47]. In practical terms, an automatic counter can be as accurate as a person looking in a microscope – and often more reproducible, since the computer applies the same counting criteria uniformly. However, differences tend to emerge at the extremes of concentration. CASA systems have been noted to overestimate very low sperm counts (<15 million/mL) and sometimes to deviate at very high counts as well[48][49]. The overestimation at low concentrations often happens because the software might count tiny debris or nonsperm cells as sperm when only a few sperm are actually present[50][51]. With so few sperm in the field, even a handful of false detections can skew the result significantly. Conversely, at extremely high concentrations (>100 million/mL), CASA can underestimate or simply show more variability, because too many sperm overlapping can confuse the counting algorithm[52][49]. In those cases, both manual and CASA methods require diluting the sample for an accurate count – as recommended by WHO guidelines. It’s worth noting that when samples are properly diluted, both manual and CASA count the same diluted aliquot, so if any error occurs due to dilution technique (e.g. pipetting mistakes), it will affect both methods similarly[53]. One study found that the SQA-Vision and a CASA (Hamilton Thorne CEROS) both significantly overestimated counts in samples below 15 million/mL compared to manual counts[48], so this seems to be a known blind spot. On the other hand, within the mid-range of sperm counts, CASA’s counting is quite reliable. Some labs even use CASA as a primary counter and then manually verify only if the count is very low or if the sample is problematic (e.g., lots of debris).

Reproducibility: CASA has an edge in consistency. The automated count eliminates subjective bias like the human tendency to round numbers or see what one expects to see. For instance, one comparative study noted the precision (repeatability) for concentration was highest with an automated analyzer (SQA) than with manual counting[54][39]. That means if you measure the same sample multiple times, the machine gives very tight, repeatable values, whereas different technicians might vary a bit more. This is a real advantage of CASA in quality control – it’s easier to standardize. In fact, devices like SQA are pre-calibrated to match manual counts using standardized samples[17], and they participate in external proficiency testing (such as CAP surveys) with good concordance to reference values[38].

Potential Issues and Solutions: When using CASA for concentration, labs have learned to implement certain safeguards. For instance, most CASA systems will flag samples that are so dense that tracking is impeded, prompting dilution. Many modern CASA software include a feature to exclude non-sperm particles by size or shape filtering[50]. For example, if a round cell (like a white blood cell) is larger than a sperm head, the software can be taught to ignore it. Nonetheless, if a sample has a lot of debris or cells of similar size to sperm (like immature germ cells), the CASA might over-count. A manual technician in such a scenario can differentiate sperm from other cells by morphology and perhaps do a separate leukocyte test; an automated system might require additional staining modules (like a leukocyte peroxidase test) to quantify WBC. This is why some CASA (like SQA) list “round cells and debris” analysis as a semi-automated or manual step[36]. In summary, for sperm counts, CASA is highly efficient and generally accurate, but labs must be aware of its limitations at the extremes and in messy samples.

2. Sperm Motility: Motility is a crucial parameter – what percentage of sperm are moving, and how vigorously. CASA was practically invented to analyze motility objectively. When comparing CASA to manual, studies show a high overall correlation in motility readings as well[47][55]. A well-configured CASA can distinguish progressive from non-progressive movement more consistently than a person (who might have difficulty judging borderline cases of slow movement). For example, one study reported correlation coefficients of r ≈0.86 for progressive motility when comparing SQA-Vision output to manual, indicating strong agreement[56]. Overall percent motility (progressive + non-progressive) had slightly lower correlation (r ≈0.74 in that study)[56] – still acceptable, but showing that sometimes the totals differ a bit.

Where CASA helps: CASA can measure detailed motion characteristics like curvilinear velocity, linearity, amplitude of lateral head displacement, etc., which manual methods simply estimate or ignore. For clinicians, those detailed metrics are usually less important than the basic percentages, but in research they’re valuable (for example, computing a “hyperactivation” fraction of sperm by specific velocity criteria). CASA also removes the human bias where an observer’s eye might be drawn to moving cells and subconsciously overestimate motility. Interestingly, it’s noted that humans sometimes overestimate motility because a moving sperm catches the eye more than a static one – whereas the computer dutifully counts everything[57][58]. Thus, in some cases CASA might report a slightly lower motile percentage than a human would, especially if many sperm are barely twitching (a human might mistakenly count them as motile). On the flip side, CASA can also overestimate motility if it misidentifies drifting non-motile sperm as moving. For instance, if an immotile sperm is nudged along by currents or by another sperm, the software might track it as if it were motile[59][60]. A trained human observer usually recognizes that subtle difference (a truly motile sperm has a beating tail, whereas a dead one being pushed doesn’t). So each method has its potential errors.

Challenges for CASA in motility: The presence of debris or non-sperm cells can confound CASA – the software might “see” a bit of debris moving in Brownian motion and count it as a slowly motile sperm. Advanced CASA systems have improved on this by tweaking algorithms (for example, ignoring objects below a certain size, or requiring a certain kind of movement track to count as sperm)[61][62]. Another challenge is sperm agglutination (when sperm stick to each other in clusters). CASA systems often struggle with agglutinated sperm – the clump might be tracked as a single moving blob or not counted at all. In fact, one summary of CASA limitations noted that heavy agglutination or very viscous samples remain difficult for automated analysis[63][64]. A human can manually separate in their count (“I see a clump of 5 sperm heads moving together, that’s 5 motile sperm”), but a computer may not parse that without specialized programming.

Bottom line on motility: For routine purposes, CASA is considered a valid alternative to manual motility assessment, with the benefit of greater reproducibility and elimination of observer bias[65][66]. Many labs appreciate that CASA can output the motility results quickly and consistently. Studies have concluded that total and progressive motility can be analyzed “interchangeably” by CASA vs manual in most cases[67], which is encouraging for automated adoption. However, the lab staff should remain vigilant for cases where CASA might be off – e.g., if CASA says 0% motile, one should verify that the sample wasn’t loaded incorrectly or that the sperm aren’t all stuck together. In practice, some labs using CASA will still do a quick manual scan of the slide if the results are unexpected (for example, a surprisingly low motility in a sample from a young, healthy patient) just to confirm there wasn’t a technical issue.

3. Sperm Morphology: This is the parameter with the greatest discrepancy between CASA and manual methods. Morphology assessment involves classifying sperm as “normal” or “abnormal” based on strict shape criteria (often the Kruger strict criteria or similar). Manually, this requires staining sperm on a slide and examining at high magnification (1000x oil). CASA systems that attempt morphology either use enhanced digital imaging or rely on simplified approaches like measuring sperm head dimensions on unstained images. The consensus in literature is that CASA morphology does not yet match the reliability of an expert human evaluator[8][68]. Many automated systems tend to overestimate the percentage of “normal” sperm because they cannot see subtle defects. For example, a CASA might measure a sperm head’s length and width and decide it’s within normal range, but it cannot see that the acrosome is small or a tiny droplet is attached to the tail – things a human would mark as abnormalities[6]. This is why numerous studies report poor correlation in morphology scores. One analysis of SQA-Vision found its morphology percentage had only r = 0.36 correlation with manual morphology[56], which is quite low (essentially, the numbers often disagreed)[69][70]. Other CASA systems have likewise shown significant differences from manual morphology results[69]. In one study, both a CASA (CEROS) and the SQA (V‐Gold model) gave higher normal morphology percentages than the manual method did[71][72] – presumably classifying some borderline abnormal sperm as “normal” when the human did not.

There have been attempts to improve CASA morphology. Some CASA software, like the Microptic SCA, allow for classification based on various criteria and even let you train the system with examples. One study by Schubert et al. reported that the SCA’s morphology results agreed with manual results[73][74], and that SCA had lower variability for morphology in both very abnormal and normal samples compared to manual, which is interesting[75]. However, it’s unclear if they used special settings or a particular staining method. In general, most labs (and the WHO manual) still recommend confirming morphology by manual review. CASA’s inability to discern fine details is a problem: for instance, vacuoles in the sperm head (tiny hollow areas in the nucleus) are linked to DNA damage but can only be seen with certain microscopy techniques – no current CASA detects those. CASA also struggles with borderline forms; a sperm that’s “just slightly under the normal head length threshold” might get classified differently depending on algorithm cut-offs, whereas a skilled morphologist can weigh all features of the cell.

Clinical impact of morphology differences: Morphology is often a decisive factor in fertility treatment decisions (e.g., severe teratozoospermia might push a couple towards IVF/ICSI). If an automated system overestimates normal forms, it might mislead clinicians. For example, suppose a sample truly has 3% normal forms (very low, severe teratozoospermia) but an automated analysis erroneously reports 10% normal. A less experienced clinician might consider 10% near normal (since WHO 5th ed reference was 4% normal as lower cutoff) and not realize the severity. A seasoned lab will likely cross-check such cases manually. Indeed, many fertility clinics explicitly perform manual morphology even if they use CASA for count/motility. They treat morphology as a separate specialized test done by an expert technician because it requires that nuanced judgement. As one fertility center put it: “Morphology – the gold standard remains man”[76]. They pointed out that CASA systems generally do not use the strict staining criteria and cannot distinguish fine morphological details or borderline forms[6]. Their stance was that real expert microscopy is essential for morphology in clinical practice[77].

Given these issues, fully automated morphology is still considered an area for improvement. Research is ongoing into AI and deep learning to analyze sperm images, which could someday approach human-level pattern recognition. But for now, CASA morphology is the weakest link – results from current CASA for morphology “correlate poorly with manual scores”[78] in general, so they should be interpreted with caution.

4. Other Parameters (Vitality, Debris, DNA fragmentation, etc.): CASA can be extended to some of these, but usually with additional steps. For example, vitality (percent live sperm) is assessed by staining (e.g., eosin-nigrosin). A CASA with a camera can count stained vs unstained sperm automatically. This is relatively straightforward and many CASA systems have a vitality module – but it’s not fully automatic since you have to prepare a stained slide manually. DNA fragmentation testing (like SCD or Sperm Chromatin Structure Assay) also can be analyzed by CASA imaging modules, but again the lab tech must perform the chemical test on the sample first. These are beyond basic semen analysis and not performed unless indicated. CASA’s role here is just to speed up counting of stained sperm vs manual counting. They work fine as tools, but they are not typically where manual vs CASA debates happen, since even manual DNA fragmentation tests rely on some instrumentation.

One area worth noting is round cell (white blood cell) detection. CASA by default doesn’t know what a round cell (WBC or immature germ cell) is versus a non-motile sperm – they all look like little round or oval blobs if not moving. Some CASA systems include an optical or chemical method to detect WBC (e.g., a peroxidase test). SQA-Vision lists the ability to report WBC (white blood cell) concentration as a semi-automated feature, likely meaning you have to do a special staining and then the device will count them[36]. Microptic SCA similarly has a leukocyte module which counts peroxidase-positive cells from images. In manual analysis, detecting a high WBC count is important (as it may indicate infection/inflammation in the male genital tract). A human will see those cells and flag it. An automated system might miss it without the specific module. This highlights a theme: fully automated analysis might overlook ancillary findings (like signs of infection or other pathologies) unless specifically programmed to detect them. A manual analyst, however, will usually note these in a report – adding clinical value beyond just the numbers.

To summarize the performance comparison:

• Concentration & Count: CASA and manual are usually equivalent (strong correlation)[47], with CASA offering faster throughput and better repeatability, but needing care at very low or very high counts[48][79].
• Motility: CASA provides objective, detailed motility assessment and correlates well with manual[47]. It improves consistency (no human bias) and can analyze motion characteristics beyond human ability. Issues to watch are misidentification of debris or drifting sperm as motile[59], and difficulties in viscous or highly clumped samples[63]. Overall, CASA is considered reliable for motility in routine use, with proper QC.
• Morphology: Manual microscopy by an expert remains the reference standard. CASA morphology is faster but often less accurate in identifying subtle defects, leading to poor correlation with manual results in many studies[55][69]. Automated morphology percentages should be interpreted cautiously and, if possible, confirmed by a human for clinical decisions.
• Variability and Reproducibility: CASA generally reduces intra- and inter-observer variability for count and motility[65][67]. Different CASA systems, however, might not agree with each other unless they’re calibrated the same – an important note if comparing results from different labs (a con is that results can be hard to compare across different CASA brands because of technical differences[80]). Manual results can vary more between operators, but a well-run lab with strict training can mitigate this.
• Speed and Throughput: CASA clearly wins on speed for large numbers of samples. For example, the SQA-Vision can produce a full basic semen analysis in 75 seconds[81]. Even including sample loading and handling time, a lab tech could run many more samples per hour with CASA than manually. Manual analysis of a single sample might take 30 minutes or more (especially if morphology is included). This means CASA can increase lab efficiency and perhaps reduce cost per test when many tests are done. However, the initial setup cost of CASA equipment is high, which is one reason not all labs have it[82]. Some smaller labs find it more cost-effective to do manual exams if their volume is low, rather than investing in an expensive machine that isn’t fully utilized. On the other hand, high-volume centers often embrace CASA to handle workload and free up skilled staff for other tasks. There is also a middle ground: some labs use CASA to do the initial analysis on every sample, but still have a technician review images or do a quick manual check for any abnormal results, combining automation with human oversight.

The pros and cons of CASA vs manual are succinctly summarized in a comparative list from a 2021 review[83], which we can paraphrase:

CASA Pros: – Much faster analysis of large numbers of samples[63]. – Reduced subjectivity – objective measurements not prone to individual bias[63]. – Higher reproducibility (precision) between repeated tests[80]. – Ability to evaluate detailed sperm motion characteristics (velocities, trajectories) that manual cannot[80]. – Digital records – possibility to save videos/images for documentation or re-analysis[80].

CASA Cons: – Still requires trained personnel, especially to prepare samples and maintain the system[63]. –Challenged by certain sample conditions – very viscous samples, samples with many round cells, debris, or sperm clumps can lead to inaccuracies[63]. – Low accuracy in morphology analysis – automated morphology hasn’t matched expert manual evaluation[80]. – Inter-instrument variability – one CASA system’s results might not identically match another’s (lack of universal standardization), making it hard to compare results if different systems are used[80]. – Potential concentration errors at extremes – very low or very high counts can show variability in CASA results[80].

Essentially, CASA excels in speed and consistency, whereas manual analysis excels in nuanced evaluation and contextual judgment. Rather than viewing one as strictly “better” than the other, many practitioners see them as complementary. CASA can handle the routine quantification and flag potential issues, and the human expert can focus on the tricky aspects and interpretation.

Degree of Automation: Do CASA Systems Require Manual Intervention?

One common question is how “hands-off” are CASA systems. The term “automated” might suggest that you press a button and walk away. In reality, most CASA systems still require some manual steps and human oversight. The extent of manual intervention varies by system:

• Sample Preparation: No matter how advanced the machine, a semen sample usually must be prepared (after the required liquefaction time). This can include mixing the sample, diluting it if it’s very concentrated, and loading it into a specialized chamber or capillary. For instance, the SQA systems require the user to aspirate 0.6 mL of semen into a disposable capillary and insert it into the device[33][84]. That step is manual. Similarly, image-based CASA requires placing a droplet of semen into a counting chamber or on a slide. A technician also needs to decide if dilution is needed (e.g., if the sample is too concentrated or too motile to count properly, per WHO guidelines both manual and CASA often require dilution above ~60 million/mL to avoid undercounting[85][86]).
• Focusing and Field Selection: Traditional CASA on a microscope (like using Microptic SCA with a standard microscope) historically needed the operator to focus the microscope and possibly select good fields of view (areas of the slide without too many clumps, etc.). Some systems have motorized stages and autofocus which can scan pre-defined patterns across the chamber – those reduce manual input. For example, Microptic offers an optional Stage Controller that can automatically move the slide to capture multiple fields[87]. However, not all labs have that hardware; many still rely on a person to adjust as needed. The new fully automated SCA SCOPE removes this need by incorporating auto-focus and motorized scanning, so the machine itself detects the sample, calibrates, focuses, and captures images without the user’s help[88][89]. The SCA SCOPE even automatically chooses which analyses to run and in what order (via AI suggestions) once the sample is loaded[90]. So, in that device, manual intervention is minimized to just loading slides and starting the run. Likewise, the SQA-Vision has a fixed optical path – once you insert the sample, it automatically performs readings. If you want to examine sperm images, you use its software interface, but focusing is handled by the device’s optics since the sample is in a fixed chamber.
• Result Verification: Even when a system runs automatically, labs often have a qualified technologist review the results. This is akin to how automated blood analyzers in a medical lab work – a machine prints out blood counts, but a lab scientist looks over flags or unexpected values. With CASA, if the analyzer flags something (e.g., “sample too dark” or “too few sperm counted for reliable motility”), a person might need to re-check the sample manually. Additionally, fully automated systems may allow or even encourage a post-run manual review of images/videos for quality control. Notably, the SQA-Vision includes the SQA-VU visualization unit for “automated sample confirmation” – essentially letting a user see the sperm on screen and confirm concentration, motility, morphology counts if desired[34]. This indicates that, while the system can operate alone, there is recognition that human oversight can add value by catching things the machine might have missed. For example, a tech might notice on the video that many sperm are sticking together, explaining a lower motile count, and can annotate the report accordingly (something the machine wouldn’t know to do).
• Maintenance and Quality Control: CASA devices require regular calibration checks and maintenance. For instance, optical systems may need focus calibration or cleaning. A fully automated device might perform self-tests (the SQA-iO does an automatic self-test and calibration at startup[91]), but humans are needed to ensure calibration standards (like checking with count beads or known control samples periodically) are met. Improper maintenance can degrade performance – one identified issue is if the optics get dirty, the machine might gradually give erroneous results【11†】. So laboratories need to have personnel in charge of CASA QC. In contrast, a manual method needs ongoing training and occasional proficiency checks, but not the same kind of mechanical maintenance.

Completely Automated Systems: As of now, fully automated semen analyzers like the SCA SCOPE are just entering the market. The SCA SCOPE, aims for total automation (multi-slide handling, etc.), but it’s not yet widely in use clinically (and not FDA cleared). Another example is the SQA-iO, a newer device by MES which is a smaller, web-connected automated analyzer. It’s essentially an evolution of SQA-Vision in a compact form, meant to be user-friendly and even suitable for point-of-care settings. MES offers a version (SQA-iOw) that is CLIA-waived**, targeting perhaps physician offices – which implies the device is automated enough that even non-lab personnel could run it with minimal training[92][93]. A CLIA-waived test is one deemed simple with low risk of error; achieving that means the process is very automated. In those systems, yes, you still manually load the sample, but virtually everything else is automated and the user interface guides the operator step by step.

Human Intervention Still Needed?: In summary, most CASA systems require at least some human intervention – particularly in preparing and loading the sample and in verifying results. Fully automated devices reduce the need for skilled microscopy during the analysis itself, but they do not eliminate the role of the technologist altogether. Even the most automated machine will require a qualified person to interpret the results in the clinical context. For instance, if an automated report comes out showing azoospermia (zero sperm), a prudent lab director will often have a technician check the sample under a microscope to confirm no sperm were seen, ruling out a machine artifact or clog. Likewise, if a fully automated system reports an extreme value (say 100% immotile sperm in a sample from a young man), a human might double-check that the sample wasn’t mishandled (e.g., too cold). These are the kinds of judgments and fail-safes that human professionals add to the process.

To directly answer: Do CASA systems require manual intervention? – Yes, typically CASA still involves manual steps, especially in the pre-analytical phase (sample handling) and often in post-analytical validation. There are now systems that automate the analytical phase completely (no need for manual focusing or counting), which is a huge advancement. But it’s not yet as simple as putting a tube in a machine and getting a final verified diagnosis without any human touch. Human oversight remains important, both to ensure the machine is functioning properly and to provide clinical interpretation of the data.

Fully Automated vs. Semi-Automated CASA: Comparison and Concerns

There is a spectrum of automation in semen analysis equipment, from systems that are essentially digital aidsfor a technician (semi-automated) to those that try to be “walk-away” analyzers (fully automated). Let’s compare these approaches and consider the concerns associated with full automation:

Semi-Automated CASA (Human-involved): This category includes setups like a standard Microptic SCA on a microscope, or a Hamilton Thorne CEROS, where a trained technician is actively involved in running the test. The person might prepare slides, focus the microscope, select fields, and perhaps initiate the analysis for each field (sometimes by pressing a foot-pedal to capture images[94][95]). The software does the counting/tracking, but the operator oversees the process. In these systems, the operator can intervene in real-time. For example, if the field has an air bubble or too many overlapped sperm, the operator notices and can skip that field, moving to a clearer one. If the autofocus isn’t perfect, they can manually fine-tune the focus to ensure sperm are sharp for analysis. This interactive approach can yield very high-quality data when done by an expert, because the human and machine are complementing each other – the human ensures good input, and the machine provides objective measurement. However, the throughput is lower (you still need that expert’s time for each sample), and consistency can depend on the operator’s diligence (one tech might choose slightly different fields than another, etc.). So semi-automated CASA still has some variability and is subject to human error if the user is not careful. It is, essentially, augmenting manual analysis with computer tools.

Fully Automated CASA (Minimal human touch during analysis): These are systems like the SCA SCOPE and SQA-Vision/SQA-iO, where once the sample is loaded and the test started, the instrument does everything internally. They feature automated stage movement, autofocus, auto-detection of sample, and pre-programmed analysis sequences. The advantages are obvious: maximal efficiency and extremely standardized processing of each sample. They do the same thing every time, without fatigue or distraction. They also open up the possibility for less-skilled personnel to run the test – for instance, a small clinic without a specialist could use a fully automated analyzer to get results, whereas a microscope-based method would require someone with microscopy skills. Indeed, the SCA SCOPE advertises that it “can be used by anyone with no prior knowledge of microscopy”[90]. Fully automated systems often incorporate multitasking (like analyzing multiple patients or multiple slides in one go)[26], further boosting lab throughput.

Concerns and Challenges with Full Automation: The flip side of removing human intervention is that you also remove human judgment from the critical moments of analysis. One concern is error detection and unusual situations. A human tech, while performing a manual or semi-automated analysis, is constantly assessing the sample’s quality – noting, for example, “this sample is very clumpy” or “there are many non-sperm cells here.” A fully automated system might not recognize those qualitative issues and could produce a misleading quantitative result. For example, if there are many aggregates of sperm (sperm stuck together), a fully automated system might undercount them (thinking a cluster is one big cell or ignoring it due to size filter). A person would at least mention in the report “sperm agglutination present,” which is clinically relevant. Similarly, debris or mucus in the sample can cause a machine to either miscount or even clog (some CASA instruments have tiny flow cell paths). An experienced technician would see debris and possibly spin down the sample or filter it if appropriate, or at least be aware that the count might be artificially high due to debris and recommend a preparatory step. A fully automated box just plows ahead.

Another concern is calibration drift or technical failure. If a microscope-based CASA’s camera goes slightly out of calibration, or an optical sensor in an SQA gets misaligned, the results could start being off without an obvious alarm. With manual analysis, there is a built-in reality check: the person sees the sperm. If a number seems strange, they can directly look at the sample. With a black-box analyzer, the lab might not realize something’s off until perhaps external QC samples reveal a problem. Therefore, labs using fully automated systems need rigorous QC programs. They often run quality control samples daily – for example, beads of known concentration to check counts, or preserved semen standards. This is analogous to other lab instruments. It’s manageable, but it means automation doesn’t eliminate the need for diligence.

Misclassification Errors: As noted earlier, CASA can misidentify objects – e.g., debris as sperm, or immotile sperm being dragged as motile. In a supervised environment, a tech could catch these errors by reviewing video or doing a quick manual check. In a fully automated run, such errors might go uncorrected. The Cleveland Clinic researchers summarized several “causes for error in semen analysis when a CASA system is used”, including incorrect identification of debris as sperm, inability to accurately characterize highly variable sperm morphology, issues with immotile sperm being pushed, and even human errors in loading affecting the machine[50][96]. They even note that if a technician pipettes or dilutes incorrectly, that error will propagate into the CASA result just as it would manually[97] – automation doesn’t fix pre-analytic errors, and in fact a non-expert user might be more prone to such errors if they trust the machine blindly. This is particularly important when CASA systems perform morphology. The SQA systems in their automated and rapid analysis don’t stain the sperm while the SCA systems require staining. The staining provides the essential parameters for diagnosis. Thus, the ability of the physician to provide meaningful feedback to the patient is limited.

Fully Automated vs Requiring Human Review: Some fully automated systems mitigate concerns by incorporating a review step. For example, the SQA-Vision, though automated, allows the user to view images of the sperm it analyzed and even attach them to reports[98][99]. This means a lab technologist can quickly scan through a gallery of images or videos post-analysis to ensure nothing glaring was missed (such as many round cells being present). However, as mentioned, without staining diagnostic detail is limited. It’s a bit like how modern hematology analyzers will flag a blood smear review if abnormal cells are suspected – the machine doesn’t simply output and stop; it facilitates a human double-check where needed. In the context of CASA, this hybrid approach might be the safest in clinical practice: use automation to get objective results fast, but have a human validate or add narrative if there are unusual findings.

Regulatory and Clinical CautiAon: It’s worth noting that regulators like the FDA are cautious with fully automated diagnostic devices. An instrument needs to demonstrate that it’s safe and effective, meaning it consistently provides correct results that a clinician can act on. The FDA-cleared systems (SQA, YO, etc.) had to undergo validation comparing to manual standards[38]. But even in their clearance, these devices usually come with labeling that they provide a semen analysis report, while often advising that results should be reviewed by appropriate medical professionals. No automated system can interpret the results in terms of diagnosis (e.g., the machine won’t tell you “this pattern suggests a varicocele or an infection”; that’s up to the physician). So automation doesn’t remove the physician or lab scientist from the equation; it just changes their role slightly – from generating raw data to verifying and interpreting data.

When Full Automation Might Fall Short: In highly individualized cases – say a patient with an extremely abnormal sample due to a rare condition – a fully automated system might not know how to handle it. For example, consider a case of globozoospermia (a rare condition where sperm have round heads with no acrosome). A human morphologist would immediately see the abnormal shape and know essentially 0% are normal. An automated system might see round heads and possibly classify many as “normal” because they fit the head size criteria (unless it’s specifically programmed otherwise). In such a case, an automated system could give an output that doesn’t convey the gravity of the situation. This is why many experts argue that “experience and responsibility cannot be automated”[100]. A human expert understands the clinical significance of certain findings in a way a current machine does not. The blog from the IVF clinic emphasized that an embryologist knows when a sample is the only one from a patient or is from a patient with known severe issues, and will take extra care and responsibility in analysis[101]. A machine treats every sample the same and cannot adjust based on patient history or the implications of being wrong.

Cost and Practicality: Fully automated systems tend to be expensive. A lab has to weigh that cost against hiring/training personnel. For some, automation is cheaper in the long run (high volume labs). For others, it may not be worth it if they still have to do manual parts or if the volume is low. As one commentary pointed out, CASA machines “don’t always provide better information” for the high price[102] – implying that unless you truly need the throughput, a well-done manual analysis might be more cost-effective and equally (if not more) informative. This ties into the next section on cost and why manual can be more expensive to the consumer even if it’s “low-tech.”

In conclusion, fully automated CASA systems represent the cutting edge of semen analysis technology and offer efficiency and standardization. They are excellent at producing rapid, objective measurements for large numbers of samples with minimal labor. However, they do not completely replace the need for skilled human involvement. The best practice in many settings is a hybrid approach: use automation to handle routine measurements (improving consistency and freeing up time), but keep expert oversight for quality control and interpretation, especially for borderline or pathological samples. Fully automated systems should be integrated into lab workflows carefully, with protocols for when to reflex to a manual check. As technology continues to improve – for example, incorporating artificial intelligence to recognize abnormal sperm forms – some of these concerns may be addressed, but the consensus is that we are not yet at a point where the “good old human eye and experienced hand” can be entirely replaced[103].

FDA Approval and Regulatory Status of CASA Systems

In the United States, medical devices (including laboratory analyzers) generally require FDA clearance or approval to be marketed for clinical use. This is particularly important for patient care, as physicians often prefer to use FDA-cleared devices for diagnostic tests. When it comes to CASA systems, few have FDA clearance in the U.S., which is a key distinction between different products:

• SQA-Vision (Medical Electronic Systems) – FDA Cleared: Yes. The SQA series has been around for a while, and earlier models like the SQA-V Gold were FDA-cleared as far back as 2002. The current SQA-Vision is also FDA-cleared for diagnostic use[17]. It’s classified as a Class II device (with special controls/probably under the hematology and pathology devices category for automated sperm analyzer). The clearance encompasses measuring standard semen parameters (count, motility, morphology index). MES’s newer device, the SQA-iO, was also cleared in 2023 as substantially equivalent to SQA-Vision[104][105]. In fact, the SQA-iO 510(k) summary explicitly states it is FDA-cleared and is intended for human semen analysis, citing equivalence to the earlier SQA-V[106][107]. So, in the U.S., the SQA line is one of the main (if not only) fully-automated options that can be used in clinical labs without special research labels. Additionally, MES’s YO Home Sperm Test is FDA-cleared for over-the-counter sale (as a Class II OTC device) – though that’s a consumer product, not a lab instrument.
• Microptic SCA (Sperm Class Analyzer) – FDA Cleared: No (Research Use in USA). Microptic’s SCA is CE-marked in Europe as an in vitro diagnostic device, but it has not obtained FDA clearance for clinical use in the U.S. In the U.S. it is sold “for research use only. [108][29]. This means any U.S. lab using SCA is essentially using it as an in-house method, under CLIA as a lab-developed test. It’s not illegal to use it, but the manufacturer can’t market it for clinical diagnostics. The lack of FDA clearance could be due to the burden of proving equivalence and consistency; it might also reflect that some aspects (like morphology) are hard to clear since even manual morphology has variability. Regardless, outside the U.S., Microptic SCA is widely used with regulatory approvals in many regions (it has IVD certification in Europe, CFDA in China, etc.). As for SCA SCOPE, being a newer device, it would likely need its own clearance if Microptic/HT pursue that in the future. 
• Hamilton Thorne IVOS/CEROS – FDA Cleared: No (as far as public info). These older CASA systems were mostly sold before FDA started actively regulating laboratory automated analyzers in this space, or they were sold into research/IVF labs that operate under CLIA. They were never specifically FDA-cleared. Now that Hamilton Thorne distributes Microptic, their focus might be on supporting that platform (which, as noted, is RUO in the U.S.).
• Other CASA – There aren’t many other players in the human clinical market. Some veterinary CASA systems (e.g., for bull semen evaluation) obviously don’t go through FDA. If any new company enters the market with a novel CASA, they’d likely go the FDA route especially if targeting andrology labs. One example is a startup or two that have looked at AI-based CASA – they would need FDA clearance to sell to clinics, but those are in developmental stages.

Why does FDA approval matter? For clinicians and patients, FDA clearance is a mark that the device has been vetted for accuracy and safety. An FDA-cleared analyzer like SQA-Vision had to undergo comparisons to manual gold standard and show it performs within acceptable limits. A device not FDA-cleared might still be perfectly good and may have lots of scientific publications supporting it. High-complexity labs under CLIA can validate and use non-FDA devices; many IVF clinics do this for specialized tests. 

It’s also worth noting that manual semen analysis itself is not an “FDA-approved” test per se – it’s a laboratory procedure. So labs can choose their tools as long as they ensure quality. Many labs continue to use manual or semi-manual methods because they trust them and they fit into quality standards. CASA devices had to overcome skepticism and prove equivalence to manual before labs and regulators accepted them.

In summary, in the U.S. the main FDA-cleared CASA systems are those from Medical Electronic Systems (SQA-Vision and derivatives)[17]. Microptic’s CASA is not FDA-cleared, so it’s officially for research use in the U.S., though it’s a leading system globally. Any fully automated system that is entirely new (like SCA SCOPE) would need to go through regulatory approval before it could be marketed for clinical use in America. 

Why a Proper Manual Analysis Often Costs More – and Does It Offer Clinical Benefits?

Patients are sometimes surprised to see that a comprehensive semen analysis at a specialized fertility clinic might cost more than a quick test elsewhere. The difference often boils down to the depth and quality of the manual analysis being performed. Here’s why a manual semen analysis done correctly can be more expensive and whether it’s “better” for diagnosis and treatment:

Labor and Expertise: A meticulous manual semen analysis is essentially a bespoke diagnostic service performed by a highly trained professional. Morphology assessment alone—properly staining the specimen, examining at least 200 sperm under oil-immersion microscopy, and accurately categorizing subtle abnormalities—requires significant time, technical skill, and years of specialized training. That expertise is costly. While automated analyzers can process samples quickly once purchased, often requiring only a few minutes of technician time to load the specimen and generate a report, they typically cannot replace the depth of information gained from careful staining and expert morphological review. In laboratories that devote the additional time needed to stain, review, and interpret sperm morphology in detail, the resulting data can be diagnostically critical and directly influence clinical decision-making. When one laboratory charges $300 for a semen analysis and another charges $100, the difference often reflects whether an hour or more of an experienced embryologist’s time is devoted to comprehensive evaluation and strict adherence to WHO protocols, versus a rapid or largely automated analysis with minimal manual review. While automation in high-volume laboratories can reduce per-test costs, the added time and expertise required for high-quality manual analysis can more than justify the additional expense by providing information that is essential for accurate diagnosis and appropriate treatment planning. [82]

2. Comprehensive Evaluation: A manually done “deluxe” semen analysis might include things that automated printouts don’t. For example, the lab might do a strict morphology with Kruger criteria (which many automated systems don’t truly do, as mentioned) – this often is billed as a separate component because it’s labor-intensive. They might also examine the sample for signs of infection (checking for increased round cells, maybe even doing a test for leukocytes), check liquefaction and viscosity carefully (if a sample doesn’t liquefy well, that’s an important finding for treatment), and assess agglutination grades (a measure of antibody-mediated sperm clumping). These qualitative assessments are part of a thorough manual analysis. An automated system might skip some of those or not report them unless manually noted. Thus, you are getting more information from a high-quality manual analysis, which could be critical for diagnosis. For instance, if a manual exam finds a lot of neutrophils in semen, the physician might investigate a silent infection in the male reproductive tract and treat that – something an automated count of “round cells” might not clearly flag without someone interpreting it.

3. Tailored to the Patient: As discussed, human-led analysis can adapt and dig deeper when needed. If a technician sees something unusual, they can pursue it (e.g., spending extra time to look at sperm viability if motility is very low – sometimes manually done by special staining on the spot). An automated system will just output numbers and stop. So the manual approach can sometimes uncover issues that a routine CASA analysis might not. This personal attention is part of what you pay for at specialized clinics.

4. Accuracy for Treatment Decisions: In fertility treatment, small differences can influence decisions. For example, if a couple has borderline values, the decision to try intrauterine insemination (IUI) versus proceeding to IVF/ICSI might hinge on exactly how low the motility or morphology is. Many physicians trust an experienced lab technician’s assessment, especially for morphology, in making that call. There is evidence that relying purely on CASA could in some cases misclassify patients. A recent study noted that using CASA results alone for IVF/ICSI treatment allocation was not consistent with manual results, potentially leading to different treatment choices[109]. For instance, if CASA underestimates how poor a sample is, a couple might attempt IUI and fail, losing time, whereas a manual analysis might have flagged that the sample is IUI-incompatible and that IVF with ICSI is needed. On the other hand, CASA might overestimate an abnormality and lead to an aggressive treatment when not needed. Therefore, having the “human touch” in analysis can improve clinical decision-making. A Cleveland Clinic publication highlighted that while automated systems are viable and very useful, conventional manual semen analysis remains the clinical standard – partly because the clinician values the expert’s nuanced input alongside the raw numbers[110]. In their words, they agree that manual analysis is the standard but also note automation can be a “viable alternative” with very good performance[110]. Ultimately, many clinics use the automated data plus a manual verification for critical parameters.

5. Patient Trust and Counseling: From a patient’s perspective, seeing a specialist spend time on their sample can be reassuring, especially if prior tests elsewhere were done quickly by a machine without explanation. Some patients might have more confidence in results that a person has double-checked (“a real person looked at my sample under a microscope and confirmed the findings”) – this is subjective, but in healthcare, perception matters too. When explaining results, a doctor might say “our embryologist noted a lot of abnormally shaped sperm, which is why we recommend IVF” – that has a human element that might feel more concrete than “the machine gave a morphology of X%.”

6. Reimbursement, CPT Coding, and Regulatory Realities (New York State):
In the United States, semen analysis reimbursement is largely governed by a limited set of CPT codes, most commonly CPT 89320 (Semen analysis; basic parameters such as volume, concentration, motility) and CPT 89310 (Semen analysis; motility and count), with CPT 89300 historically used for limited qualitative assessments. Notably, strict morphology, vitality staining, leukocyte differentiation, or advanced interpretive work are often not separately reimbursed or are bundled into these basic codes. Under Medicare, reimbursement for CPT 89320 typically ranges from approximately $15–$40, depending on geographic locality adjustments, while many commercial insurers reimburse only modestly higher amounts, often in the $30–$80 range. These payments frequently fail to reflect the true cost of performing a comprehensive, high-quality manual semen analysis.

In New York State, additional regulatory requirements further widen the gap between reimbursement and actual cost. Laboratories performing semen analysis must hold appropriate CLIA certification and, if testing is patient-facing, a New York State Department of Health CLEP (Clinical Laboratory Evaluation Program) permit, both of which impose strict personnel qualifications, validation requirements, quality control, proficiency testing, documentation, and inspection standards. A properly performed manual semen analysis may require 45–90 minutes of hands-on time by a trained andrology technologist, whose compensation—when accounting for wages, benefits, ongoing competency assessment, and regulatory training—often translates to $75–$120 per hour or more in fully loaded labor costs. Additional per-test expenses include specialized supplies (counting chambers, stains, slides, coverslips), microscope acquisition and maintenance, quality-control materials, LIS documentation, and overhead related to compliance with CLIA and NYS CLEP standards. When these factors are conservatively combined, the true cost of a comprehensive manual semen analysis frequently falls in the range of $200–$400 or higher, particularly when morphology staining and detailed review are included.

Because third-party reimbursement rarely accounts for these regulatory, labor, and expertise-driven costs, many laboratories—especially hospital-based or high-volume reference labs—adopt automated or semi-automated systems to remain financially viable. Automation allows laboratories to process greater specimen volumes with reduced hands-on time per sample, helping align operational costs with fixed or declining reimbursement rates. However, this economic pressure also explains why laboratories that continue to offer detailed manual semen analysis, performed under strict CLIA and New York State CLEP standards, must charge higher self-pay rates—and why the additional time and expertise involved can yield diagnostically important information that automation alone may not capture.

Is a manual analysis better for diagnosis and treatment? It depends on context:

• If done properly, a manual analysis provides a rich, detailed picture that can directly inform diagnosis (e.g., diagnosing teratozoospermia, leukocytospermia, asthenozoospermia, etc., with confidence). It can catch subtle things (like the presence of rare sperm defects or anomalies) that an automated system might not report. For example, manual identification of pinhead sperm or tails with coiled ends might lead to different considerations that an automated system lumping everything as “abnormal” wouldn’t differentiate.
• Automation ensures consistency and can reduce false findings (like eliminating the risk that an untrained technician simply did a poor job counting). For fundamental parameters like count and motility, an automated result may be just as clinically useful as a manual one – and more reproducible. If a manual analysis is not done to a high standard (for instance, some general labs might only visually estimate count instead of doing a proper count, leading to large errors), then a CASA from a reputable machine would actually be superior.

So the quality matters: Manual done correctly vs. automated done correctly – they mostly agree on key numbers except morphology. Manual done incorrectly vs. automated – automated will be better because at least it’s objective and calibrated.

The reason some top fertility centers still lean on manual or at least manual confirmation is that they handle complex cases where every detail counts. They value that a senior andrologist’s judgement is involved. They also often couple manual analysis with other tests (like a detailed sperm morphology analysis with strict criteria) that CASA can’t fully replicate. For basic screening (e.g., a first semen analysis for a routine check), an automated analysis from an FDA-cleared device in a reference lab can be perfectly adequate and is certainly better than no test at all or an unreliable test. But when results are borderline or couples are making big decisions, many doctors like having that manual component.

Cost aspect revisited: A manual analysis that is more expensive is usually more expensive for a reason: time and expertise. If you see a low price for a semen analysis, it could mean they are using an automated quick test or not doing morphology, etc. If you see a higher price, ask what it includes – often it will include morphology by strict criteria, perhaps viability staining if needed, and so forth. Those add value for diagnosis.

It’s not that labs charge more because it’s manual per se; they charge more because it’s a longer, more involved procedure by a specialist. Automation can cut those labor costs. One source explicitly asked “Is CASA more costly than manual testing?” and answered that CASA is “a bit costlier than manual analysis”for the lab due to the equipment cost, but its precision and speed are worth it[111]. That perspective suggests that if a lab has CASA, the initial investment is high, but presumably they recoup it via volume. For a patient, you might not directly see CASA vs manual pricing differences because it depends on the lab’s billing model. However, a fully manual “WHO standard” test might indeed be priced higher in many cases.

Conclusion on this point: A correctly performed manual semen analysis is often more expensive because it’s a highly skilled, time-intensive service – but it can offer excellent diagnostic insights, especially for complex or borderline cases. It remains the gold standard for certain assessments like morphology, which can be crucial for treatment planning. CASA systems, especially those that are FDA-approved, provide an alternative that is efficient and standardized and generally matches manual analysis in most areas except morphology[112]. Many modern labs take a hybrid approach: using CASA for speed and consistency in count/motility, and relying on manual examination for morphology and any flags that automation raises. This approach tries to offer the “best of both worlds” – the objectivity and throughput of machines with the discernment of human experts.

In the end, the choice between CASA and manual is not an either/or of good vs bad – it’s about using the right tool for the right task and ensuring quality control. Patients and clinicians should be aware that an “unbiased perspective” means recognizing the strengths of CASA (objective, reproducible results for most metrics[113]) as well as its challenges (morphology limitations, need for human validation in some cases[55]). Likewise, manual methods have strengths (contextual analysis, expert insight[5]) and weaknesses (subjectivity, variability[10]). When done properly, both approaches can yield clinically useful results – and indeed, studies suggest automated analysis can be used interchangeably with manual for many parameters without compromising clinical accuracy[39]. But the highest quality semen analysis might very well involve both: automation to crunch the numbers and a human to oversee and interpret them, ensuring that patients get accurate diagnoses and optimal treatment guidance.

---

References

1. Tumallapalli S. et al. (2021). The validity and reliability of computer-aided semen analyzers in performing semen analysis: a systematic review. Translational Andrology and Urology, 10(7):3069-3077. [47][114]
2. Lammers J. et al. (2021). Comparison of two automated sperm analyzers using 2 different detection methods versus manual semen assessment. J Gynecol Obstet Hum Reprod, 50(8):102084 (abstract). [71][14]
3. Cleveland Clinic – Dr. Agarwal (2018). Response to reflections on YO Home Sperm Test validation. (Comments on automated vs manual analysis). [110][39]
4. Microptic SCA – Hamilton Thorne (2023). Product info: SCA SCOPE – Automatic Semen Analysis System. (Features of fully automated CASA). [42][28]
5. Medical Electronic Systems (2023). SQA-Vision Automated Semen Analyzer – Product Overview. (FDA compliance and automation features). [40][35]
6. IVF.bg Clinic (2025). Manual sperm analysis vs. CASA – why we choose manual precision? (Blog article detailing manual vs CASA differences from a clinical perspective). [4][6]
7. Henkel R. & Agarwal A. (2020). Artificial Intelligence in Andrology: Part 1 – semen analysis to image analysis. (Review on CASA improvements and AI integration). [67][63]
8. MES Medical Electronic Systems – FDA 510(k) Summary (2022). SQA-iO Sperm Quality Analyzer.(Device description and predicate SQA-V). [32][16]
9. Cheon K. et al. (2019). Smartphone-based CASA versus laboratory CASA and manual analysis. Int J Clin Urol (study comparing automated systems). [115][78]
10. Dearing C. et al. (2014). Automated semen analysis (SCA) vs. manual (WHO 5th): correlation and differences. (Findings cited in systematic review). [69][48]
11. MES Global – Studies & Publications. “MES SQA-Vision and Microptic SCA Compared to Manual Analysis” (ESHRE poster). (Comparative data on SQA vs SCA vs manual). [56][116]
12. World Health Organization (2021). WHO Laboratory Manual for the Examination and Processing of Human Semen, 6th Ed. (Standard for manual semen analysis procedures). [3][117]
13. FDA Device Listing (2002). SQA-V Sperm Quality Analyzer (K021746). (Original FDA clearance of SQA-V). [104][105]
14. Merck Veterinary Manual. Computer-assisted semen analysis, image of bull sample. (Illustration of CASA output with motile tracks). [118]【25†】
15. R.D. Singh et al. (2012). Correlation of SQA II-C results with manual morphology. Asian J Androl, 13:59-63. (Noted high correlation of an automated system’s morphology with manual in one study)[73].

---

[1] [8] [9] [10] [12] [47] [48] [49] [50] [51] [52] [53] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [67] [68] [69] [70][73] [74] [75] [78] [79] [80] [83] [85] [86] [96] [97] [112] [114] [115]  The validity and reliability of computer-aided semen analyzers in performing semen analysis: a systematic review – PMC 

https://pmc.ncbi.nlm.nih.gov/articles/PMC8350227

[2] [3] [11] [13] [14] [15] [41] [54] [71] [72] [82] Comparison of two automated sperm analyzers using 2 different detection methods versus manual semen assessment – ScienceDirect

https://www.sciencedirect.com/science/article/abs/pii/S246878472100026X

[4] [5] [6] [7] [76] [77] [100] [101] [102] [103] Manual sperm analysis vs. computer system (CASA) — why do we choose manual precision? | Инвитро клиника София

https://www.ivf.bg/en/blog/manualen-spermalen-analiz-vs-kompyutrna-sistema-casa-zashcho-izbirame-rchnata-preciznost

[16] [32] [33] [84] [91] [104] [105] [106] [107] accessdata.fda.gov

https://www.accessdata.fda.gov/cdrh_docs/pdf22/K220828.pdf

[17] [18] [30] [31] [37] [38] [39] [43] [44] [45] [46] [65] [66] [110] [113]  Cleveland Clinic response to reflections on YO Home Sperm Test validat 

https://yospermtest.com/blogs/yo-blogs/cleveland-clinic-response-to-reflections-on-yo-home-sperm-test-validation

[19] [21] SCA® CASA System automatic sperm analyzer – HT CASA

https://www.micropticsl.com/products/sperm-class-analyzer-casa-system

[20] [22] [23] [24] [25] [26] [87] [88] [89] [90] [94] [95] Automatic Sperm Analysers – LabIVF Homepage – LabIVF

https://labivf.com/automatic-sperm-analysers

[27] [28] [29] [42] [108] SCA CASA System-Microptic

https://www.hamiltonthorne.com/product/sca-scope

[34] [92] [93] SQA-iO – Automated Semen Analyzer – Medical Electronic Systems

[35] [36] [40] [81] SQA-Vision – Automated Semen Analyzer – Medical Electronic Systems

https://mes-global.com/products/automated-semen-analysis-solutions/sqa-vision-automated-semen-analyzer

[98] [PDF] The full picture of Sperm Analysis SQA-V & Vision Sperm

https://wm-vision.com/img/PDF/SQA-V%20and%20Vision%20Sperm_Rev%201.0_03.2024_brochure_EN%20LQ.pdf

[99] SQA-VISION | Automated Semen Analysis | IVF and Sperm Banking …

https://www.youtube.com/watch?v=ukIns4rPgHw

[109] ICSI/IVF treatments allocation using CASAs compared to… – Medicine

https://journals.lww.com/md-journal/fulltext/2025/02070/icsi_ivf_treatments_allocation_using_casas.5.aspx

[111] Why CASA Is Better Than Manual Semen Analysis Methods

[116] Medical Electronic Systems Studies and Publications

https://mes-global.com/support/medical-electronic-systems-studies-and-publications

[117] The sixth edition of the WHO Laboratory Manual for the Examination …

https://www.sciencedirect.com/science/article/pii/S0015028221022986

[118] Image:Computer-assisted semen analysis, good sample-Merck Veterinary Manual

https://www.merckvetmanual.com/multimedia/image/computer-assisted-semen-analysis-good-sample